SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N 1994 The diagnosis of osteoporosis. J Bone Miner Res 9: 11371141.
  • 2
    Kelly PJ, Harris M 1995 Genetic regulation of peak bone mass. Acta Paediatr Suppl 411: 2430.
  • 3
    Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S 1987 Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80: 706710.
  • 4
    Gueguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G 1995 Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 10: 20172022.
  • 5
    Efstathiadou Z, Tsatsoulis A, Ioannidis JP 2001 Association of collagen Ialpha 1 Sp1 polymorphism with the risk of prevalent fractures: A meta-analysis. J Bone Miner Res 16: 15861592.
  • 6
    Mann V, Hobson EE, Li B, Stewart TL, Grant SF, Robins SP, Aspden RM, Ralston SH 2001 A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 107: 899907.
  • 7
    Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FE, Grant SF, Hofman A, van Leeuwen JP, Pols HA, Ralston SH 1998 Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338: 10161021.
  • 8
    Weisgraber KH, Mahley RW 1996 Human apolipoprotein E: The Alzheimer's disease connection. FASEB J 10: 14851494.
  • 9
    Contois JH, Anamani DE, Tsongalis GJ 1996 The underlying molecular mechanism of apolipoprotein E polymorphism: Relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease. Clin Lab Med 16: 105123.
  • 10
    Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ 1994 Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 272: 16661671.
  • 11
    Frikke-Schmidt R 2000 Context-dependent and invariant associations between APOE genotype and levels of lipoproteins and risk of ischemic heart disease: A review. Scand J Clin Lab Invest Suppl 233: 325.
  • 12
    Kohlmeier M, Salomon A, Saupe J, Shearer MJ 1996 Transport of vitamin K to bone in humans. J Nutr 126 (Suppl 4): 1192S1196S.
  • 13
    Knapen MH, Hamulyak K, Vermeer C 1989 The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med 111: 10011005.
  • 14
    Parhami F, Garfinkel A, Demer LL 2000 Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 20: 23462348.
  • 15
    Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL 1997 Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680687.
  • 16
    Salamone LM, Cauley JA, Zmuda J, Pasagian-Macaulay A, Epstein RS, Ferrell RE, Black DM, Kuller LH 2000 Apolipoprotein E gene polymorphism and bone loss: Estrogen status modifies the influence of apolipoprotein E on bone loss. J Bone Miner Res 15: 308314.
  • 17
    Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y 1997 Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12: 14381445.
  • 18
    Cauley JA, Zmuda JM, Yaffe K, Kuller LH, Ferrell RE, Wisniewski SR, Cummings SR 1999 Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk—The Study of Osteoporotic Fractures. J Bone Miner Res 14: 11751181.
  • 19
    Pluijm SM, Dik MG, Jonker C, Deeg DJ, Kamp GJ, Lips P 2002 Effects of gender and age on the association of apolipoprotein E ϵ4 with bone mineral density, bone turnover and the risk of fractures in older people. Osteoporos Int 13: 701709.
  • 20
    Kohlmeier M, Saupe J, Schaefer K, Asmus G 1998 Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif Tissue Int 62: 278281.
  • 21
    Johnston JM, Cauley JA, Ganguli M 1999 APOE 4 and hip fracture risk in a community-based study of older adults. J Am Geriatr Soc 47: 13421345.
  • 22
    von Muhlen DG, Barrett-Connor E, Schneider DL, Morin PA, Parry P 2001 Osteoporosis and apolipoprotein E genotype in older adults: The Rancho Bernardo study. Osteoporos Int 12: 332335.
  • 23
    Booth SL, Tucker KL, Chen H, Hannan MT, Gagnon DR, Cupples LA, Wilson PW, Ordovas J, Schaefer EJ, Dawson-Hughes B, Kiel DP 2000 Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 71: 12011208.
  • 24
    Heikkinen AM, Kroger H, Niskanen L, Komulainen MH, Ryynanen M, Parviainen MT, Tuppurainen MT, Honkanen R, Saarikoski S 2000 Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women? Maturitas 34: 3341.
  • 25
    Stulc T, Ceska R, Horinek A, Stepan J 2000 Bone mineral density in patients with apolipoprotein E type 2/2 and 4/4 genotype. Physiol Res 49: 435439.
  • 26
    Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA 1991 Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 7: 403422.
  • 27
    van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA 2002 The incidence of vertebral fractures in men and women: The Rotterdam Study. J Bone Miner Res 17: 10511056.
  • 28
    McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, Vasikaran S, Kanis JA 1993 The assessment of vertebral deformity: A method for use in population studies and clinical trials. Osteoporos Int 3: 138147.
  • 29
    WHO 1992 International Statistical Classification of Diseases and Related Health Problems, 10th rev., vol. 1. WHO, Geneva, Switzerland.
  • 30
    Burger H, van Daele PL, Algra D, van den Ouweland FA, Grobbee DE, Hofman A, van Kuijk C, Schutte HE, Birkenhager JC, Pols HA 1994 The association between age and bone mineral density in men and women aged 55 years and over: The Rotterdam Study. Bone Miner 25: 113.
  • 31
    van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C 1994 Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 7: 7478.
  • 32
    Folstein MF, Folstein SE, McHugh PR 1975 “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189198.
  • 33
    Dupuy AM, Badiou S, Ritchie K, Mas E, Descomps B, Cristol JP, Touchon J 2001 Discrepancies between apolipoprotein E phenotyping and genotyping in the elderly. Clin Chem Lab Med 39: 405413.
  • 34
    Artiga MJ, Bullido MJ, Frank A, Sastre I, Recuero M, Garcia MA, Lendon CL, Han SW, Morris JC, Vazquez J, Goate A, Valdivieso F 1998 Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum Mol Genet 7: 18871892.
  • 35
    Bullido MJ, Artiga MJ, Recuero M, Sastre I, Garcia MA, Aldudo J, Lendon C, Han SW, Morris JC, Frank A, Vazquez J, Goate A, Valdivieso F 1998 A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet 18: 6971.